Steven L. Barriere

Chief Tech/Sci/R&D Officer at

Theravance Biopharma US, Inc.

Health Technology

Consumer Services

Commercial Services

Profile

Steven L.
Barriere is currently a Clinical Professor at The University of California, San Francisco and a Vice President-Clinical & Medical Affairs at Theravance Biopharma US, Inc. He previously worked as a Vice President-Clinical & Medical Affairs at Innoviva, Inc. He holds a doctorate degree from The University of California, San Francisco.

Steven L. Barriere active positions

Companies	Position	Start
The University of California, San Francisco The University of California, San Francisco Other Consumer ServicesConsumer Services Functions as a College/University	Corporate Officer/Principal	24/03/2009
Theravance Biopharma US, Inc. Theravance Biopharma US, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in research and development for the treatment in lungs, gastrointestinal tract and infectious diseases	Chief Tech/Sci/R&D Officer	-

All active positions of Steven L. Barriere

Former positions of Steven L. Barriere

Companies	Position	End
INNOVIVA, INC.	Chief Tech/Sci/R&D Officer	-

See the detail of Steven L. Barriere's experience

Training of Steven L. Barriere

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Steven L. Barriere's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	3
Innoviva, Inc. Innoviva, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that manufactures respiratory drugs	Health Technology
The University of California, San Francisco The University of California, San Francisco Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Theravance Biopharma US, Inc. Theravance Biopharma US, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in research and development for the treatment in lungs, gastrointestinal tract and infectious diseases	Commercial Services